Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$12.80 -0.32 (-2.44%)
At close: Oct 23, 2026 · 4:00 PM EDT

Eloxx Pharmaceuticals (ELOX) Gains from Sales and Divestitures (2016 - 2023)

Updated

Eloxx Pharmaceuticals (ELOX) reported Gains from Sales and Divestitures of $1,000 for FY2025, down 97.4% from $38,000 in FY2024.

Analysis

Eloxx Pharmaceuticals (ELOX) Gains from Sales and Divestitures (2016 - 2023) Analysis & Trends

Dating back to FY2015, Eloxx Pharmaceuticals' Gains from Sales and Divestitures record includes 9 years.

  • The FY2025 figure ranks as the lowest annual Gains from Sales and Divestitures since FY2021.
  • According to Business Quant data, Gains from Sales and Divestitures came in at $38,000 in FY2024 (-86.8%), $288,000 in FY2023 and -$84,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Eloxx Pharmaceuticals 87.44 Mn 13.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 33,000.00
Sep 30, 2023 242,000.00
Sep 30, 2016 149,728.00
API Access

Eloxx Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ELOX&period=max&api_key=YOUR_API_KEY